Clinical Trials in East London, Eastern Cape
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled27 locationsNCT07071623
Recruiting
Phase 2Phase 3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Breast Neoplasms
Bristol-Myers Squibb500 enrolled293 locationsNCT06926868
Recruiting
Not Applicable
Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis
Drug Resistant TuberculosisRifampin-resistant Tuberculosis
Albert Einstein College of Medicine280 enrolled1 locationNCT06590428
Recruiting
Not Applicable
Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
HIV InfectionsTreatment AdherenceMen
Desmond Tutu HIV Foundation3,642 enrolled2 locationsNCT05602376